Oct 27, 2026
Chinese drug maker Hengrui surges in Hong Kong after 89% rise in third-quarter net profit
Jiangsu Hengrui Pharmaceuticals surged more than 12 per cent in Hong Kong following strong third-quarter results, as positive momentum continues to buoy Chinese biotech stocks.
Hengrui, one of China’s largest drug makers, reported a 20.55 per cent rise in third-quarter revenue to 8.95 billion yuan (US$1.34 billion), beating analyst estimates of 8.55 billion yuan amid stronger innovative drug sales.
Net profit reached 2.46 billion yuan for the three months ended September 30, jumping 88.92 per...